Characterization of C-alkyl amidines as bioavailable covalent reversible inhibitors of human DDAH-1.
Characterization of C-alkyl amidines as bioavailable covalent reversible inhibitors of human DDAH-1.
复制标题
DOI:
10.1002/cmdc.201000392
复制
发表时间:
2011-01-03
期刊:
影响因子:
3.4
通讯作者:
Robertus, Jon D.
中科院分区:
文献类型:
--
作者:
Lluis, Matthew;Wang, Yun;Monzingo, Arthur F.;Fast, Walter;Robertus, Jon D.
C-alkyl amidine analogs of asymmetric Nω,Nω -dimethyl-L-arginine are dual-targeted inhibitors of both human DDAH-1 and nitric oxide (NO) synthase, and provide a promising scaffold for developing therapeutics to control NO overproduction in a variety of pathologies including septic shock and some cancers. Using a two-part clickchemistry-mediated activity probe, a homologated series of C-alkyl amidines are ranked for their ability to inhibit DDAH-1 within cultured HEK 293T cells. N5-(1-iminopentyl)-L-ornithine was determined to be the most potent compound in vitro (Kd = 7 μM) as well as in cultured cells, and the binding conformation and covalent reversible mode of inhibition was investigated by comparison of interactions made with DDAH-1 and a catalytically inactive C274S variant as gauged by Xray crystallography and isothermal titration calorimetry. By interrupting the ability of the inhibitor to form a covalent bond, the contribution of this interaction can be estimated. These results suggest further stabilization of the covalent adduct as a promising strategy for lead optimization in the design of effective reagents to block NO synthesis.
登录
查看更多内容
DOI:
10.1006/bbrc.1994.1511
发表时间:
1994-04-29
影响因子:
3.1
作者:
BAYDOUN, AR;MANN, GE
通讯作者:
MANN, GE
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
影响因子:
3.9
作者:
LIANG, TC;ABELES, RH
通讯作者:
ABELES, RH
影响因子:
4.4
作者:
Böger, RH
通讯作者:
Böger, RH
影响因子:
--
作者:
Linsky, Thomas W.;Monzingo, Arthur F.;Fast, Walter
通讯作者:
Fast, Walter